IP Library Granted Patent US 11,547,801
Granted Patent B2
US 11,547,801 · App. 16/495,868 · Granted Jan 10, 2023

Auto-injector

Inventors: Bryan C. Grygus (Clifton Park, NY); Alfred Marino (Housatonic, MA); Rachel P. Arnott (San Francisco, CA); Scott Barton (Clifton Park, NY); Bart E. Burgess (Virginville, PA); Richard Gildersleeve (Rensselaer, NY); Alexei Goraltchouk (Cambridge, MA); Daniel Halbig (Ballston Lake, NY); Christopher Kanel (Hudson, NY); Trevor Langley (Rensselaer, NY)
Assignee: REGENERON PHARMACEUTICALS, INC.
A61M5/2033A61M5/3202A61M2005/2013A61M2205/103A61M2209/088
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,547,801
App. No.
16/495,868
Granted
Jan 10, 2023
Kind
B2
Abstract

An injection device includes a carrier, a needle, a driver coupled to the needle, the driver being slidable relative to the carrier between a retracted configuration and a deployed configuration, a shuttle configured to move the driver between the retracted configuration and the deployed configuration, and a stop configured to move from a first configuration to a second configuration, wherein the stop is configured to maintain the driver in the deployed configuration, and movement of the stop from the first configuration to the second configuration allows the shuttle to move the driver from the deployed configuration to the retracted configuration.

Claims (51)

1. An injection device, comprising:

a housing,

a needle;

a driver coupled to the needle, the driver being slidable relative to the housing between a retracted configuration and a deployed configuration;

a shuttle configured to move in a longitudinal direction to move the driver between the retracted configuration and the deployed configuration; and

a stop configured to move from a first configuration to a second configuration, wherein the stop is configured to maintain the driver in the deployed configuration, and movement of the stop from the first configuration to the second configuration allows the shuttle to move further in the longitudinal direction to move the driver to retract the needle.

2. The injection device of claim 1 , wherein the shuttle is movable from a first position to a second position, and from the second position to a third position, wherein:

when the shuttle is in the first position, the driver is in the retracted configuration;

when the shuttle is in the second position, the driver is in the deployed configuration;

when the shuttle is in the third position, the needle is retracted.

3. The injection device of claim 2 , wherein the first position and the third position are different.

4. The injection device of claim 3 , wherein the shuttle moves in one direction along an axis to move from the first position to the second position, and from the second position to the third position; and

wherein the shuttle is configured to move only in the one direction.

5. The injection device of claim 2 , further including an impediment, wherein, before activation, the driver is in contact with the impediment, and is prevented from moving out of the retracted configuration by the impediment.

6. The injection device of claim 5 , wherein the impediment is integral with the housing.

7. The injection device of claim 6 , further including a carrier disposed within the housing, wherein movement of the carrier relative to the impediment moves the driver out of contact with the impediment, allowing the driver to move from the retracted configuration to the deployed configuration.

8. The injection device of claim 7 , further including a resilient member coupled to the shuttle, wherein, after the driver is moved out of contact with the impediment, the resilient member is configured to expand from a first compressed state to a second compressed state to move the shuttle from the first position to the second position, wherein, after the stop is moved from the first configuration to the second configuration, the resilient member is configured to expand from the second compressed state to a resting state to move the shuttle from the second position to the third position.

9. The injection device of claim 1 , wherein the shuttle is configured to move along a first axis, the driver is configured to move along a second axis, and the first axis and the second axis are perpendicular to one another.

10. The injection device of claim 1 , further comprising:

a vial configured to be in fluid communication with the needle;

a piston configured to move within the vial;

a motor configured to drive the piston; and

a controller coupled to the motor, wherein the controller is configured to:

receive an indication that the injection device is positioned in contact with a user;

after receiving the indication, sending a signal to the motor to drive the piston in a first direction to put the needle and the vial in fluid communication and move the driver from the retracted configuration to the deployed configuration; and

without requiring any intervention by a user after receiving the indication, and after sending the signal to drive the motor in the first direction, automatically sending a signal to the motor to drive the piston in a second direction to move the driver to retract the needle.

11. The injection device of claim 10 , wherein the housing encloses the vial, the piston, the motor, the controller, and the needle when the driver is in the retracted configuration, wherein the needle extends out of the housing when the driver is in the deployed configuration.

12. The injection device of claim 10 , further including a cover or a shield that contains a distal-most portion of the needle when the driver is in the retracted configuration.

13. The injection device of claim 10 , further including an audio module, a visual module, and a haptic module, each of the modules being coupled to the controller and configured to provide feedback to a user of the injection device.

14. The injection device of claim 10 , further including a top that seals an opening of the vial, the top including a portion including a rubber material that is permeable to a sterilant, wherein the needle includes a proximal-most portion configured to be coupled with the vial, and, before the needle and vial are in fluid communication with one another, the proximal-most portion of the needle is disposed within the portion formed of the rubber material.

15. The injection device of claim 10 , further including a cantilever coupled to the controller, and movable by the needle, wherein, when the driver is in the retracted configuration, the cantilever forms part of an open circuit that signals to the controller that the driver is in the retracted configuration, and when the driver is in the deployed configuration, the cantilever forms part of a closed circuit that signals to the controller that the driver is in the deployed configuration.

16. An injection device, comprising:

a housing,

a needle;

a driver coupled to the needle, the driver being slidable relative to the housing between a retracted configuration and a deployed configuration;

a shuttle configured to move in a longitudinal direction to move the driver between the retracted configuration and the deployed configuration;

a stop configured to move from a first configuration to a second configuration, wherein the stop is configured to maintain the driver in the deployed configuration, and movement of the stop from the first configuration to the second configuration allows the shuttle to move further in the longitudinal direction to move the driver to retract the needle; and

a carrier disposed within the housing, a deployment gear coupled to the carrier, and a retraction gear coupled to the carrier, wherein:

the driver is coupled to the deployment gear and the retraction gear; and

the shuttle includes a rack gear configured to engage the deployment gear and the retraction gear, wherein direct engagement of the rack gear with the deployment gear moves the driver from the retracted configuration to the deployed configuration, and direct engagement of the rack gear with the retraction gear moves the driver from the deployed configuration to retract the needle.

17. The injection device of claim 16 , wherein the rack gear directly contacts only one of the deployment gear and the retraction gear at any time.

18. The injection device of claim 16 , wherein the rack gear is configured to:

drive rotation of the deployment gear in a first direction to move the driver from the retracted configuration to the deployed configuration; and

drive rotation of the retraction gear in the first direction to move the driver from the deployed configuration to retract the needle.

19. The injection device of claim 16 , wherein the driver includes a first rack and a second rack, wherein the first rack is configured to engage the deployment gear, and the second rack is configured to engage the retraction gear, wherein the first rack and the second rack are located on opposing sides of the driver.

20. An injection device, comprising:

a carrier including a stop, wherein the stop has a first end fixed to a remainder of the carrier, and a free second end,

a first gear coupled to the carrier;

a needle;

a driver coupled to the carrier, the first gear, and the needle, the driver being slidable relative to the carrier between a retracted configuration and a deployed configuration;

a shuttle including a rack gear configured to drive rotation of the first gear, wherein the rotation of the first gear moves the driver from the retracted configuration to the deployed configuration, wherein the free second end of the stop is configured to at least temporarily prevent movement of the shuttle while the driver is in the deployed configuration.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 26, 2021
From: GRYGUS, BRYAN C.; MARINO, ALFRED; ARNOTT, RACHEL P.; BARTON, SCOTT; BURGESS, BART E.; GILDERSLEEVE, RICHARD; GORALTCHOUK, ALEXEI; HALBIG, DANIEL; KANEL, CHRISTOPHER; LANGLEY, TREVOR
To: REGENERON PHARMACEUTICALS, INC.
Reel/Frame 056351/0609 →
Continuity (2)
Provisional Application 62502278 · May 5, 2017
Related Publication 20200086051A1 · Mar 19, 2020
Cited By (5)
US 1,122,440 US 12,226,613 US 12,226,614 US 12,533,298 US 12,691,213